Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells 22,607 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 22,607 shares of the business’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $3.85, for a total value of $87,036.95. Following the transaction, the chief executive officer now owns 178,519 shares of the company’s stock, valued at approximately $687,298.15. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Amit Gupta also recently made the following trade(s):

• On Wednesday, October 2nd, Amit Gupta sold 7,543 shares of Cardlytics stock. The shares were sold at an average price of $3.08, for a total value of $23,232.44.

Cardlytics Trading Down 1.3 %

Shares of NASDAQ:CDLX opened at $3.78 on Friday. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.77 and a quick ratio of 1.77. The business’s 50-day moving average is $3.61 and its 200 day moving average is $7.37. The firm has a market capitalization of $184.40 million, a P/E ratio of -0.86 and a beta of 1.67. Cardlytics, Inc. has a 1 year low of $2.89 and a 1 year high of $20.52.

Cardlytics (NASDAQ:CDLX) last issued its earnings results on Wednesday, August 7th. The company reported ($0.09) EPS for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.12. The firm had revenue of $69.64 million for the quarter, compared to the consensus estimate of $75.39 million. Cardlytics had a negative return on equity of 17.96% and a negative net margin of 50.21%. The company’s revenue was down 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.57) earnings per share. On average, research analysts predict that Cardlytics, Inc. will post -1.72 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Cardlytics

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Canton Hathaway LLC boosted its position in shares of Cardlytics by 95.7% during the second quarter. Canton Hathaway LLC now owns 4,500 shares of the company’s stock worth $37,000 after buying an additional 2,200 shares during the period. XTX Topco Ltd purchased a new position in Cardlytics in the second quarter valued at $107,000. Banco Santander S.A. acquired a new stake in Cardlytics in the first quarter valued at $199,000. SG Americas Securities LLC acquired a new stake in Cardlytics in the third quarter valued at $45,000. Finally, Quest Partners LLC raised its stake in Cardlytics by 160.4% in the second quarter. Quest Partners LLC now owns 17,956 shares of the company’s stock valued at $147,000 after buying an additional 11,061 shares in the last quarter. Institutional investors and hedge funds own 68.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on CDLX shares. Needham & Company LLC cut Cardlytics from a “buy” rating to a “hold” rating in a report on Thursday, August 8th. Northland Securities cut Cardlytics from an “outperform” rating to a “market perform” rating and dropped their price objective for the company from $7.00 to $5.00 in a report on Friday, August 16th. Bank of America lowered Cardlytics from a “neutral” rating to an “underperform” rating and decreased their target price for the company from $4.00 to $3.50 in a research report on Thursday, August 15th. Craig Hallum lowered Cardlytics from a “buy” rating to a “hold” rating in a research report on Thursday, August 8th. Finally, Evercore ISI started coverage on Cardlytics in a research report on Friday, October 11th. They issued an “in-line” rating and a $4.00 price target for the company. One research analyst has rated the stock with a sell rating and six have given a hold rating to the company’s stock. According to data from MarketBeat.com, Cardlytics has a consensus rating of “Hold” and a consensus target price of $6.92.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.